Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Liver disease | Image credit: Crystal light - stock.adobe.com

Fatty Liver Found in Half of Patients With Type 2 Diabetes, Study Finds

By Pearl Steinzor

June 13th 2025

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent study, urging early detection and comprehensive care.

DASH diet | Image credit: Albi - stock.adobe.com

DASH-Style Diet Lowers Blood Pressure in Type 2 Diabetes

By Pearl Steinzor

June 10th 2025

vials of insulin | Image credit: Sherry Young - stock.adobe.com

AI Matches Physician Accuracy in Insulin Dosing for T2D

By Laura Joszt, MA

May 30th 2025

Type 2 diabetes graphic | Image Credit: greenapple78 - stock.adobe.com

Concurrent Hypertension, Type 2 Diabetes Linked to Higher Mortality Risk

By Brooke McCormick

May 29th 2025

Insulin cost | Image credit: Pixel-Shot - stock.adobe.com

Diabetes Health Gains Outpace Economic Progress, Study Finds

By Pearl Steinzor

May 16th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background

More News

USA graphic

January 5th 2022

Study Supports Call for Geographically Tailored Diabetes Care Interventions

Patients with diabetes living in rural or deprived regions in the United States are less likely to achieve optimal care for their condition, according to a new cross-sectional study.

t1d graphic

December 30th 2021

Top 5 Most-Read Type 1 Diabetes Articles of 2021

The most popular type 1 diabetes articles published in 2021 included new research on screening and updated coverage policy.

stethoscope on US flag

December 27th 2021

Analysis Highlights Disparities in GLP-1 RA Access

An analysis uncovered racial, ethnic, and socioeconomic inequities regarding access to glucagon-like peptide-1 receptor agonists among US patients with diabetes.

blue cross

December 23rd 2021

Family History of T2D May Increase MACE Risk in Those With T1D

A study carried out in Taiwan found that a family history of type 2 diabetes (T2D) may increase the risks of diabetes-related complications in those with type 1 diabetes (T1D).

diabetes graphic

December 20th 2021

Top 5 Most-Read Diabetes Articles of 2021

New research on semaglutide and empagliflozin appear on this year’s list of most-read diabetes articles.

diversity graphic

December 15th 2021

Study: Racial-Ethnic Disparities in T1D Technology Use Worsened From 2017 to 2019

Between coverage years 2017 and 2019, racial-ethnic disparities in diabetes technology use worsened among Medicare beneficiaries with type 1 diabetes.

eye graphic

December 8th 2021

Experts Examine the Association Between Retinal Damage, DKD Presence in Patients With T2D

Results of a cross-sectional study fond diabetic kidney disease (DKD) was associated with retinal changes in patients with type 2 diabetes (T2D).

technology graphic

December 6th 2021

Review: Smartphone Apps May Improve Outcomes in Gestational Diabetes

Results of a systemic review found evidence potentially supporting the use of smart phone applications among mothers with gestational diabetes.

diabetes graphic

December 1st 2021

Does Gender-Affirming Hormone Therapy Affect T2D Risk?

Results of a cohort study showed that transfeminine individuals may be at a higher risk for type 2 diabetes (T2D) compared with cisgender females, but revealed little evidence that gender-affirming hormone therapy impacts diabetes risk.

pill graphic

November 29th 2021

Variability in Statin Use Seen Among Finnish T2D Population

Data showed differences in statin use to prevent cardiovascular disease among Finnish patients with type 2 diabetes.

Jordan Messler, MD, SFHM,

November 22nd 2021

Contributor: CMS Has Decided to Put Its Muscle Behind Glycemic Management—Why Now?

Jordan Messler, MD, SFHM, FACP

CMS' introduction of 3 new electronic clinical quality measures, 2 of which are focused on inpatient glycemic management, signal a strong commitment to shine a light on this often-overlooked area, according to the chief medical officer at Glytec.

Robert A. Gabbay, MD, PhD

November 16th 2021

Dr Robert Gabbay Outlines How the Health Equity Now Initiative Addresses Diabetes Care Disparities

Hayden E. Klein

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, explains the Health Equity Now initiative and how it shines a light on health disparities.

Robert A. Gabbay, MD, PhD

November 10th 2021

Dr Robert Gabbay on COVID-19 Vaccinations in the Diabetes Community

Hayden E. Klein

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses COVID-19 vaccinations among people with diabetes as they have been disproportionally affected by the pandemic.

November 10th 2021

Challenges With Implementing the Diabetes Prevention Program for Medicare Beneficiaries in an Integrated Health System

Inga Gruß, PhD Alison Firemark, MA Dea Papajorgji-Taylor, MPH Stephanie L. Fitzpatrick, PhD

This study presents challenges of implementing the CDC-approved Diabetes Prevention Program for Medicare beneficiaries at a large, integrated health care delivery system.

woman at doctor's

November 8th 2021

Analysis Details Factors Associated With T2D Development Among Women With PCOS

Results of a cross-sectional study detail characteristics among women with polycystic ovary syndrome (PCOS) who develop type 2 diabetes.

america graphic

November 3rd 2021

Study Evaluates Impact of Food Environments on T2D Risk

Results of a longitudinal study indicate community food accessibility factors may impact type 2 diabetes risk among veterans.

inclusivity image

October 31st 2021

Research Highlights Racial/Ethnic Diabetes Disparities Based on Age of Diagnosis

New research underscores racial/ethnic diabetes disparities in the United States.

Robert Gabbay, MD, PhD

October 29th 2021

Dr Robert Gabbay Discusses SGLT2 Inhibitor Uptake Among Cardiologists, Nephrologists

Hayden E. Klein

As time goes on, we're finding out more and more benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors, said Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association.

old man

October 26th 2021

Intensifying Diabetes Medication Regimen at Hospital Discharge May Not Benefit Older Patients

Results of a retrospective study found no benefits among older patients whose diabetes medication was intensified following short hospital admissions.

October 20th 2021

Hypoglycemia Upon Hospital Admission From Long-term Care: Health Care Resource Use

Naushira Pandya, MD, CMD Alyssa Trenery, PharmD, MPH Ray Sieradzan, PharmD Claudia Gabai, MPH Anastasia Ermakova, PharmD Yan Xiong, MS

This analysis of a hospital billing database describes inpatient length of stay, intensive care unit length of stay, comorbidities, and costs for patients with diabetes after admission with hypoglycemia from long-term care or home.

diabetes graphic

October 18th 2021

Insulin Analogs, Pen Delivery Devices Most Used Among Patients With T2D

Using data from a nationally representative sample, investigators sought to determine trends in insulin device use.

Light Drinking Linked With Lower Risk of Type 2 Diabetes for Some Women

October 15th 2021

Light Drinking Linked With Lower Risk of Type 2 Diabetes for Some Women

Hayden E. Klein

Some alcohol, but not more than 1 drink per day, was linked to a 55% lower risk of type 2 diabetes in women with a history of gestational diabetes.

diabetes graphic

October 11th 2021

Study Finds Statin Use Associated With Diabetes Progression

Using electronic medical record data from Veterans Affairs, researchers found statin use was associated with a greater risk of diabetes progression.

October 8th 2021

Patient and Supporter Factors Affecting Engagement With Diabetes Telehealth

Margaret F. Zupa, MD John D. Piette, PhD Shelley C. Stoll, MPH D. Scott Obrosky, MS Monique Boudreaux-Kelly, PhD Ada O. Youk, PhD Luc Overholt, MD Ranak Trivedi, PhD Michele Heisler, MD, MPH Ann-Marie Rosland, MD, MS

Family support with medication management and recent urgent self-management concerns are 2 novel factors, among others, that predict completion of diabetes telehealth calls.

Diabetic Nephropathy, Obesity Increase COVID-19 Mortality Risk in Patients With Type 2 Diabetes

October 4th 2021

Diabetic Nephropathy, Obesity Increase COVID-19 Mortality Risk in Patients With Type 2 Diabetes

Hayden E. Klein

Patients with T2D had elevated blood glucose levels but there were no notable differences in levels between surviving and non-surviving patients with T2D.

Deepak Bhatt, MD, MPH

September 29th 2021

Dr Deepak Bhatt on the Importance of In-Hospital Initiation of SGLT2 Inhibitors

Deepak L. Bhatt, MD, MPH, outlines the benefits of starting patients on sodium glucose co-transporter 2 (SGLT2) inhibitors while they are hospitalized.

doctor writing script

September 27th 2021

Medicaid Expansion Linked With Reduction in Uninsurance and Improved Blood Pressure, Glucose Control Measures

Results of a representative study of patients at federally qualified health centers found Medicaid expansion was associated with reduced rates of uninsurance, improved blood pressure and diabetes control measures, and progress in closing racial care disparities over 5 years.

David G. Armstrong

September 21st 2021

Managing the Surge: Delayed Chronic Wound Care During COVID-19

David G. Armstrong, DPM, MD, PhD

Encourage Further SGLT2 Inhibitor Treatment for Diabetes, Kidney Disease, Expert Says

September 20th 2021

Encourage Further SGLT2 Inhibitor Treatment for Diabetes, Kidney Disease, Expert Says

Hayden E. Klein

New data from the CREDENCE trial shows that the sodium glucose co-transporter 2 (SGLT2) inhibitor canagliflozin may reduce hyperkalemia risk in people with type 2 diabetes and chronic kidney disease who are using RAAS inhibitors.

sugar rising

September 10th 2021

Presentation Outlines Long-term CV Risks of Gestational Diabetes

A session at the 5th annual Heart in Diabetes Conference highlights the long-term risks of gestational diabetes.

...

6 7 8 9 10 11 12 13 14

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions